Cargando…
Breaking the crosstalk of the cellular tumorigenic network: Hypothesis for addressing resistances to targeted therapies in advanced NSCLC
In the light of current treatment developments for non-small cell lung cancer (NSCLC), the idea of a plastic cellular tumorigenic network bound by key paracrine signaling pathways mediating resistances to targeted therapies is brought forward. Based on a review of available preclinical and clinical...
Autores principales: | Langhammer, Stefan, Scheerer, Joachim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522169/ https://www.ncbi.nlm.nih.gov/pubmed/28402937 http://dx.doi.org/10.18632/oncotarget.16674 |
Ejemplares similares
-
Breaking the crosstalk of the Cellular Tumorigenic Network by low-dose combination therapy in lung cancer patient-derived xenografts
por: Gürgen, Dennis, et al.
Publicado: (2022) -
Rationale for the design of an oncology trial using a generic targeted therapy multi-drug regimen for NSCLC patients without treatment options (Review)
por: LANGHAMMER, STEFAN
Publicado: (2013) -
SNRPB promotes the tumorigenic potential of NSCLC in part by regulating RAB26
por: Liu, Nianli, et al.
Publicado: (2019) -
Advancement of regulating cellular signaling pathways in NSCLC target therapy via nanodrug
por: Li, Wenqiang, et al.
Publicado: (2023) -
Addressing skepticism of the critical brain hypothesis
por: Beggs, John M.
Publicado: (2022)